Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-04-17

Clinical Trial Update: Stage Ib Trial of mSMART With Varenicline [Phase 1]

View source ↗

Summary

A Phase 1 (Stage Ib) trial of mSMART with varenicline for nicotine dependence has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varenicline (varenicline)
  • mSMART

Snippet

Sponsor: Duke University | Conditions: Nicotine Dependence | Phase 1 | Status: WITHDRAWN